tykhr
sign in
free sign up
Inhibikase Therapeutics Inc
Biotechnology
Healthcare
IKT
90.01 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.69
52 week high
3.97
high
1.72
52 week low
0.00
low
1.60
growth
35.00 %
previous Close
1.68
P/E ratio
market cap
128 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-9.92 M
27.51 %
eps
0.00 %
26.67 %
eps surprise
-37.50 %
net profit margin
-991552300.00 %
0.00 %
operating incoming
-10.83 M
25.80 %
net change in cash
4.30 M
-74.62 %
cash on hand
77.74 M
5.86 %
cost of revenue
24.16 K
0.00 %
top